OvaScienceSM (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported third quarter 2014 financial results.
“The interest in our AUGMENT treatment from global fertility specialists has exceeded our expectations, resulting in OvaScience achieving one of its 2014 goals ahead of schedule,” said Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience.
Help employers find you! Check out all the jobs and post your resume.
“The interest in our AUGMENT treatment from global fertility specialists has exceeded our expectations, resulting in OvaScience achieving one of its 2014 goals ahead of schedule,” said Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience.
Help employers find you! Check out all the jobs and post your resume.
